Emerging MS Therapies, Advances in Brain Science Among Themes of AAN Meeting/About-the-Society/News/Emerging-MS-Therapies,-Advances-in-Brain-Science-A … read morePosted At: National MS Society
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tabletsMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Time is vision: The importance of the early discovery and diagnosis of optic neuritisMultiple Sclerosis Journal, Volume 23, Issue 14, Page 1806-1807, December 2017. … read morePosted At: MS Journal
Psychiatric disorders in children with demyelinating diseases of the central nervous systemMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Brain’s lymphatic vessels as new avenue to treat multiple sclerosisThe brain’s lymphatic vessels appear to carry previously unknown messages from the brain to the immune system that ultimately cause the disease symptoms. Blocking those...
- Next story Survey Suggests African Americans with MS May Engage in Less Physical Activity than Caucasians with
- Previous story Researchers Funded by National MS Society Pinpoint Direct Damage to Nerve Connections in Mice, Indep
Join Our Mailing List
- World’s Largest MS Research Conference: Understanding MS and New Strategies to Restore Function
- Conceptual framework to study role of exercise in multiple sclerosis
- Insights into microbiome research 3: Who’s there versus what are they doing?
- Updates From ECTRIMS Research Conference
- Environmental factors may trigger onset of multiple sclerosis
- Genetic Ancestry Associated with Clinical Course in Hispanic-Latinos: Study is Ongoing
- Prognostic information for people with MS: Impossible or inevitable?
- New immunotherapy targeting blood-clotting protein
- Animal models of multiple sclerosis: From rodents to zebrafish
- Inclusion criteria used in trials of people with progressive multiple sclerosis